Brent Saunders keeps rolling out the changes at Bausch + Lomb; Incyte CSO to exit next month

→ Bausch + Lomb CEO Brent Saunders told Andrew Dunn on Wednesday that he’d take time to “digest” the $1.75 billion deal he made for Xiidra “but will continue to look to source smaller deals.” Meanwhile, Saunders isn’t dealing in small leadership updates these days as he continues to retool the team. Asli Gevgilili, who worked with Saunders when she was in charge of human resources at Allergan, will replace Kelly Webber as Bausch + Lomb’s chief human resources officer; Jonathon Kellerman was Saunders’ chief compliance officer at Allergan and he’ll have the same position here; ex-AcuFocus president and CEO Al Waterhouse has been named chief supply chain and operations officer; TJ Crawford (chief communications officer) and Manisha Narasimhan (chief corporate development and digital officer) are taking on newly-established positions; and Dennis Asharin — Bausch + Lomb’s chief global manufacturing and supply chain officer — will shift to head of quality.

Preview

来源: EndPoints

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP

LOG IN

BECOME A PREMIUM SUBSCRIBER

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。